Targeting RBM5 may help disrupt ‘undruggable’ MYC in childhood leukemia
- Aug 4
- 1 min read
Scientists from St. Jude Children’s Research Hospital and collaborators have identified the RNA-binding protein RBM5 as a potential vulnerability in a set of difficult-to-treat childhood leukemias.
Hay đó. Phần helpful guide giải thích gọn mà vẫn đủ ý.
https://example.com
Hay đó. Phần b9t-verify giải thích gọn mà vẫn đủ ý.
https://example.com